Berlin, Germany

Hortensia Faus Gimenez

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Bayer Pharma Aktiengesellschaft. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hortensia Faus Gimenez. Retrieved from https://idiyas.com/inventor/hortensia-faus-gimenez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hortensia Faus Gimenez: Innovator in Medicinal Chemistry

Introduction

Hortensia Faus Gimenez is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of innovative compounds for treating diseases.

Latest Patents

Hortensia holds 1 patent related to N-[4-(quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides. This invention encompasses intermediates and methods for their production, as well as their use in treating and preventing diseases, especially hyperproliferative diseases.

Career Highlights

Hortensia is currently employed at Bayer Pharma Aktiengesellschaft, where she continues to advance her research and development efforts in the pharmaceutical industry. Her work focuses on creating effective medicinal products that can significantly impact patient care.

Collaborations

Throughout her career, Hortensia has collaborated with notable colleagues, including Duy Nguyen and Hermann Künzer. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Hortensia Faus Gimenez is a trailblazer in the field of medicinal chemistry, with her innovative work paving the way for advancements in disease treatment. Her contributions are invaluable to the pharmaceutical industry and the health sector as a whole.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…